This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sygnis Bioscience Gmbh & Co Kg. Active years: 2010-2011.
Company Filing History:
Years Active: 2010-2011
Title: Wolf-Ruediger Schaebitz: Innovator in Neurological Treatments
Introduction
Wolf-Ruediger Schaebitz is a notable inventor based in Germany. He has made significant contributions to the field of neurology, particularly in the treatment of neurological conditions. His innovative approach focuses on the use of hematopoietic growth factors to address various neurological issues.
Latest Patents
Wolf-Ruediger Schaebitz holds a patent titled "Methods Of Treating Neurological Conditions With Hematopoietic Growth Factors." This invention relates to a method of treating neurological conditions in mammals by administering hematopoietic growth factors such as granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony stimulating factor (GMCSF). The patent also outlines methods for screening compounds that bind to GCSF or GMCSF receptors found on neuronal cells, which can provide neuroprotective, neuroproliferative, and/or STAT gene activation activities. He currently has 5 patents.
Career Highlights
Wolf-Ruediger Schaebitz is associated with Neurovision Pharma GmbH, where he continues to work on innovative treatments for neurological conditions. His research and development efforts are aimed at improving the quality of life for individuals suffering from these conditions.
Collaborations
He collaborates with notable colleagues, including Armin Schneider and Carola Krueger, to advance research in the field of neurology.
Conclusion
Wolf-Ruediger Schaebitz is a dedicated inventor whose work in hematopoietic growth factors has the potential to transform the treatment of neurological conditions. His contributions to the field are significant and continue to inspire further research and innovation.